# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 17


In regulation 27 (amendment of regulation 36 (conditions for manufacturer’s licence)) for “, omit paragraphs (4) to (7)” substitute—
“—
(a) in paragraph (4)—
(i) for “The requirements” substitute “Where a manufacturer’s licence relates to the manufacture or assembly of a medicinal product in, or import of a medicinal product into, Northern Ireland, the requirements”;
(ii) for “provisions of a manufacturer’s” substitute “provisions of that”;
(b) in paragraph (6), after “by way of wholesale dealing” insert “in Northern Ireland”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/17 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.